This podcast episode takes the format of an educational quiz show that explores pharmaceutical drug development, with a focus on FDA guidelines and safety protocols. The hosts discuss important topics including nitrosamines and mutagenic impurities in medications, the four phases of clinical trials, and the role of psychedelics in treating mental health conditions and end-of-life care. The episode concludes with a discussion about the future of pharmaceuticals, including AI drug development and personalized medicine.